Genome‐wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c‐Kit, CD117) and oestrogen receptor‐α (ERα) in response to therapeutic radiation
Charlotte Westbury(Institute of Cancer Research), Clare M. Isacke(Breast Cancer Now), Betania Mahler‐Araujo(National Health Service), Anita Grigoriadis(London Cancer), Marjan Iravani(Institute of Cancer Research), Alan Mackay(Institute of Cancer Research), Jorge S. Reis‐Filho(AstraZeneca (France)), Kerry Fenwick(Institute of Cancer Research), David Robertson(Institute of Cancer Research), Alan Ashworth(University of California, San Francisco), Suzanne Parry(Institute of Cancer Research), Tim Dexter(Institute of Cancer Research), John Yarnold(Institute of Cancer Research)
Cited by 37
Related Papers
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials
|The Lancet Oncology|2013|1.4k
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
|Cancer Cell|2017|1.3k
<i>RAS</i> Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
|New England Journal of Medicine|2012|1k